medigraphic.com

2007, Number 4

<< Back

Med Sur 2007; 14 (4)

Pulmonary coronary thrombosis and thromboembolia like presentation of syndrome antiphospholipids in a man

Flores GLE, Gómez MO, Marroquín FE, Herrera LA, Herrera BH

Language: Spanish
References: 13
Page: 196-199
PDF size: 75.67 Kb.


ABSTRACT

Antiphospholipid syndrome is a systemic illness characterized by arterial or venous thrombosis, recurrent fetal lost, and high title of antiphospholipid antibodies such as lupic anticoagulant and anticardiolipin antibodies. It represent a stage prothrombotic in which early and indefinite anticoagulant treatment is indicated. There are numerous clinical and biochemical criteria for the diagnosis, however always is suitable to individualize. Deep venous thrombosis is the most frequent feature in the diagnosis (32% of cases). This is a young patient with diagnosis of Antifosfolipid Syndrome with an inusual beginning: coronary arterial thrombosis.


REFERENCES

  1. Levine JS, Branch DW, Rauch J. The Antiphospholipid syndrome. N Engl J Med 2002; 346: 752-763.

  2. Hess DC, Krauss J, Adams RJ, Nichols FT, Zhang D, Rountree HA. Anticardiolipin antibodies: a study of frequency in TIA and stroke. Neurology 1991; 41: 525-528.

  3. Villa P, Hernández MC, López-Fernández MF, Battle J. Prevalence, follow-up and clinical significance of the anticardiolipina antibodies in normal subjects. Thromb Haemost 1994; 72: 20.

  4. Clair W, Jones B, Rogers JS. Deep venous thrombosis and circulating anticoagulant in systemic lupus erythematosus. Am J Dis Child 1981; 135: 230-233.

  5. Ravelli A, Martín A. Antiphospholipid Syndrome. Pediatr Clin N Am 2005; 52: 469-491.

  6. Cervera R, Piette JC, Font J et al. Antiphospholipid syndrome: clinical and immunologic manifestations and patterns of disease expression in a cohort of 1000 patients. Arthitis Rheum 2002; 46: 1019.

  7. Zuckerman E, Toubi E, Shiran A et al. Anticardiolipin antibodies and acute myocardial infarction in non-SLE patients: A controlled prospective study. Am J Med 1996; 100: 381.

  8. Roman MJ, Shanker BA, Davis A, Lockshin MD, Sammaritano L et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Engl J Med 2003; 349: 2399-2406.

  9. Morton KE, Gavaghan TP, Krilis SA et al. Coronary artery bypass graft failure. An autoimmune phenomenon? Lancet 1986; 2: 1353.

  10. Piette JC, Cacoub P, Wechsler B. Renal manifestations of the antiphospholipid syndrome. Sem Arthritis Rheum 1994; 23: 357-366.

  11. Bertolaccini ML, Hughes GRV. Antiphospholipid antibody testing: Which are most useful for diagnosis? Rheum Dis Clin N Am 2006; 32: 455-463.

  12. Pelletier S, Landi B, Piette JC. Antiphospholipid syndrome as the second cause of non-tumorous Budd-Chiari syndrome. J Hepatol 1994; 21: 76-80.

  13. Calvo P, Síndrome antifosfolípido. Protocolos diagnósticos y terapéuticos en Pediatría,14: 85-94




2020     |     www.medigraphic.com